- Home
- WHWK vs ACRE Comparison
WHWK vs ACRE Comparison
Compare WHWK & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHWK | ACRE |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.8M | 191.4M |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | WHWK | ACRE |
|---|---|---|
| Price | $3.20 | $3.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 8 |
| Target Price | ★ $7.71 | $5.00 |
| AVG Volume (30 Days) | 284.5K | ★ 628.4K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 18.07% |
| EPS Growth | ★ 86.02 | 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | $7,145,000.00 | ★ $54,833,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.86 |
| P/E Ratio | ★ N/A | $2.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.97 | $3.29 |
| 52 Week High | $5.50 | $5.89 |
Technical Indicators
Market Signals| Indicator | WHWK | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 27.79 | 21.52 |
| Support Level | $2.46 | N/A |
| Resistance Level | $3.05 | $5.37 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 13.64 | 0.68 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.